Supreme Court rebuked pharma firm for cough syrups allegedly linked to over 18 child deaths in Uzbekistan.
Bench refused to quash summoning order issued under Drugs and Cosmetics Act for substandard drugs.
Court emphasised severe damage to India's international image due to the incident.


